J. Braun

发表

The Expectations and Challenges of Wildlife Disease Research in the Era of Genomics: Forecasting with a Horizon Scan-like Exercise.

Steven D. Miller, Devon R. O'Rourke, Bruno M. Ghersi, 2019, The Journal of heredity.

Whole-genome analysis of mycobacteria from birds at the San Diego Zoo

W. Pfeiffer, B. Rideout, J. Braun, 2017, PloS one.

Decreases in inflammatory and coagulation biomarkers levels in HIV-infected patients switching from enfuvirtide to raltegravir: ANRS 138 substudy.

J. Molina, S. Mourah, F. Caron, 2013, The Journal of infectious diseases.

Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial.

C. Delaugerre, J. Molina, S. Gallien, 2011, The Journal of antimicrobial chemotherapy.

Coupling gene-based and classic veterinary diagnostics improves interpretation of health and immune function in the Agassiz's desert tortoise (Gopherus agassizii).

R. Lewison, T. Esque, K. Nussear, 2017, Conservation physiology.

A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes

J. Braun, E. Tuaillon, F. Damond, 2003, AIDS.

Seroepidemiologic of Potential Pathogens in Obligate and Facultative Scavenging Species in

Christine K. Johnson, B. Rideout, J. Braun, 2015 .

Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial

J. Molina, J. Braun, J. Viard, 2016, AIDS research and therapy.

Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial

J. Molina, J. Braun, J. Viard, 2016, AIDS Research and Therapy.

Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia

D. Kuritzkes, C. Delaugerre, J. Molina, 2011, AIDS.

High Concentration of Raltegravir in Semen of HIV-Infected Men: Results from a Substudy of the EASIER-ANRS 138 Trial

C. Delaugerre, J. Molina, V. Furlan, 2009, Antimicrobial Agents and Chemotherapy.

Virologic Diagnosis and Follow-up of Children Born to Mothers Infected by HIV-1 Group O

V. Ferré, V. Lemée, J. Braun, 2004, Journal of acquired immune deficiency syndromes.

Plasma virion reverse transcriptase activity and heat dissociation-boosted p24 assay for HIV load in Burkina Faso, West Africa

M. Vray, V. Lemée, J. Braun, 2005, AIDS.

MOLECULAR METHODS TO DETECT MYCOPLASMA SPP. AND TESTUDINID HERPESVIRUS 2 IN DESERT TORTOISES (GOPHERUS AGASSIZII) AND IMPLICATIONS FOR DISEASE MANAGEMENT

M. Schrenzel, B. Rideout, J. Braun, 2014, Journal of wildlife diseases.

Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules.

B. Spire, C. Moog, A. Siccardi, 1999, AIDS.

A communal catalogue reveals Earth’s multiscale microbial diversity

Rick L. Stevens, William A. Walters, Nicole M. Gaudelli, 2017, Nature.

HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene

Luc Montagnier, Dominique Rousset, L. Montagnier, 1998, The Lancet.

Hepatitis and splenitis due to systemic tetratrichomoniasis in an American white pelican (Pelecanus erythrorhynchos)

R. E. Burns, B. Rideout, J. Braun, 2013, Journal of Veterinary Diagnostic Investigation.

SEROLOGIC AND MOLECULAR EVIDENCE FOR TESTUDINID HERPESVIRUS 2 INFECTION IN WILD AGASSIZ'S DESERT TORTOISES, GOPHERUS AGASSIZII

M. Schrenzel, K. Berry, B. Rideout, 2012, Journal of wildlife diseases.

Seroepidemiologic Survey of Potential Pathogens in Obligate and Facultative Scavenging Avian Species in California

Christine K. Johnson, B. Rideout, J. Braun, 2015, PloS one.

Clinical and Pathological Aspects of Systemic Isospora Infection in Blue-crowned Laughing Thrushes (Garrulax courtoisi) at Jersey Zoo

M. Stidworthy, J. López, J. Braun, 2019, Journal of Avian Medicine and Surgery.

Phenotypic Susceptibility to Nonnucleoside Inhibitors of Virion-Associated Reverse Transcriptase From Different HIV Types and Groups

P. Roques, V. Lemée, J. Braun, 2004, Journal of acquired immune deficiency syndromes.

HIV-1 and HIV-2 produce different amounts of 2-long terminal repeat circular DNA in vitro

J. Braun, J. Plantier, F. Simon, 2008, AIDS.

Differences in proviral DNA load between HIV-1- and HIV-2-infected patients

F. Brun-Vézinet, G. Chêne, V. Lemée, 2008, AIDS.

Using the gut microbiota as a novel tool for examining colobine primate GI health

Se Jin Song, J. Metcalf, R. Knight, 2016 .

Herpesvirus surveillance and discovery in zoo-housed ruminants

M. Schrenzel, B. Rideout, J. Braun, 2021, PloS one.

Plasma RNA quantification and HIV-1 divergent strains.

J. Braun, F. Damond, J. Plantier, 2003, Journal of acquired immune deficiency syndromes.

Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimen

C. Delaugerre, J. Molina, P. Yeni, 2010, AIDS.

Pharmacokinetic study of raltegravir in HIV-infected patients with end-stage liver disease: the LIVERAL-ANRS 148 study.

J. Molina, D. Vittecoq, S. Haim-Boukobza, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial.

D. Neau, P. Morlat, C. Michelet, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of resistance mutation patterns in historical plasma HIV RNA genotypes with those in current proviral HIV DNA genotypes among extensively treated patients with suppressed replication

C. Delaugerre, B. Marchou, J. Braun, 2012, HIV medicine.

Switch from enfuvirtide to raltegravir in virologically suppressed multidrug-resistant HIV-1-infected patients: a randomized open-label trial.

C. Delaugerre, C. Katlama, Y. Yazdanpanah, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A cell line-based bioassay of non β-chemokine-related HIV suppressive activity

J. Braun, A. Beretta, 2000 .

ASSESSMENT OF DISEASE RISK ASSOCIATED WITH POTENTIAL REMOVAL OF ANTHROPOGENIC BARRIERS TO MOJAVE DESERT TORTOISE (GOPHERUS AGASSIZII) POPULATION CONNECTIVITY

T. Esque, K. Nussear, B. Rideout, 2021, The Journal of Wildlife Diseases.

Impact on Health-Related Quality of Life of a Switch From Enfuvirtide to Raltegravir Among Multidrug-Resistant HIV-1–Infected Patients: A Randomized Open-Label Trial (EASIER-ANRS 138)

P. Morlat, B. Spire, J. Molina, 2010, HIV clinical trials.

Social network analysis and whole-genome sequencing to evaluate disease transmission in a large, dynamic population: A study of avian mycobacteriosis in zoo birds

J. Fowler, W. Pfeiffer, L. Hungerford, 2021, PloS one.

Pharmacokinetic study of raltegravir in HIV-infected patients with end-stage liver disease: the LIVERAL-ANRS 148 study.

J. Molina, D. Vittecoq, S. Haim-Boukobza, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis and splenitis due to systemic tetratrichomoniasis in an American white pelican (Pelecanus erythrorhynchos)

R. E. Burns, B. Rideout, J. Braun, 2013, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.